EXPRESSION AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN HYPERTROPHIC VENTRICLE OF HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY

被引:67
|
作者
TAKEMURA, G
FUJIWARA, H
MUKOYAMA, M
SAITO, Y
NAKAO, K
KAWAMURA, A
ISHIDA, M
KIDA, M
UEGAITO, T
TANAKA, M
MATSUMORI, A
FUJIWARA, T
IMURA, H
KAWAI, C
机构
[1] KYOTO UNIV, FAC MED,DEPT INTERNAL MED,DIV 3,54 KAWARA CHO, SAKYO KU, KYOTO 606, JAPAN
[2] KYOTO UNIV, FAC MED, DEPT INTERNAL MED, DIV 2, KYOTO 606, JAPAN
[3] KYOTO WOMENS UNIV, KYOTO, JAPAN
关键词
VENTRICLE; HYPERTENSION; ATRIAL NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1161/01.CIR.83.1.181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the ventricular expression of atrial natriuretic peptide (ANP) in human hypertrophic hearts, we conducted an immunohistochemical study of 130 endomyocardial biopsy specimens obtained from the right side of the ventricular septum (RVB), left ventricular free wall (LVB), or both from a total of 80 patients: 44 patients with hypertrophic cardiomyopathy (HCM), 14 with apical hypertrophic cardiomyopathy (APH), 13 with hypertensive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive heart failure. ANP was not seen in ventricular myocytes in controls but was identified in biopsy specimens of hypertrophic hearts, and its distribution was characteristic in each hypertrophic group: 15 RBV (37%) and two LVB (7%) of the HCM group, one RBV (7%) and two LVB (18%) of the APH group, and zero RVB (0%) and five LVB (46%) of the HHD group. Clinical data (including echocardiographic, hemodynamic, and angiographic data) were not directly related to ventricular ANP expression in HCM, APH, or HHD with one exception. In HHD patients, LVB specimens with ANP showed greater ventricular wall thickness than LVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens of HCM or ANP-present LVB specimens of HHD had greater myocyte size than did the ANP-absent specimens. In addition, in HCM patients, the ANP-present RVB specimens showed more severe fibrosis and myofiber disarray than did the ANP-absent specimens. We conclude that a failing state and hemodynamic overload are not likely to be indispensable for ANP expression in human hypertrophic ventricles and that ventricular ANP expression occurs as a response to disease-specific changes: hemodynamic overload in HHD and histological changes such as myocardial fiber disarray, hypertrophy of myocytes, and fibrosis in HCM, which may reflect the characteristic distribution of intraventricular ANP.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [31] Natriuretic peptide receptor expression in human failing hearts
    Naruko, T
    Ueda, M
    Haze, K
    vanderWal, AC
    vanderLoos, CM
    Ito, H
    Fukuda, Y
    Kitano, K
    Kawashima, K
    Becker, AE
    [J]. CIRCULATION, 1997, 96 (08) : 1476 - 1476
  • [32] Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts
    Shinsuke Hanatani
    Yasuhiro Izumiya
    Seiji Takashio
    Sunao Kojima
    Megumi Yamamuro
    Satoshi Araki
    Taku Rokutanda
    Kenichi Tsujita
    Eiichiro Yamamoto
    Tomoko Tanaka
    Shinji Tayama
    Koichi Kaikita
    Seiji Hokimoto
    Seigo Sugiyama
    Hisao Ogawa
    [J]. Heart and Vessels, 2014, 29 : 231 - 237
  • [33] Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts
    Hanatani, Shinsuke
    Izumiya, Yasuhiro
    Takashio, Seiji
    Kojima, Sunao
    Yamamuro, Megumi
    Araki, Satoshi
    Rokutanda, Taku
    Tsujita, Kenichi
    Yamamoto, Eiichiro
    Tanaka, Tomoko
    Tayama, Shinji
    Kaikita, Koichi
    Hokimoto, Seiji
    Sugiyama, Seigo
    Ogawa, Hisao
    [J]. HEART AND VESSELS, 2014, 29 (02) : 231 - 237
  • [34] King of Hearts for Ace of Spades: Apical Hypertrophic Cardiomyopathy
    Siewe, Daku
    Nichols, Kyle B.
    Furney, Scott L.
    Littmann, Laszlo
    [J]. AMERICAN JOURNAL OF MEDICINE, 2014, 127 (01): : 31 - 33
  • [35] INCREASE IN ATRIAL PRESSURE RELEASES ATRIAL-NATRIURETIC-PEPTIDE FROM ISOLATED PERFUSED RAT HEARTS
    RUSKOAHO, H
    THOLKEN, H
    LANG, RE
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1986, 407 (02): : 170 - 174
  • [36] CALPAIN ACTIVITY OF HYPERTROPHIC HEARTS FROM HYPERTENSIVE RATS
    CICILINI, MA
    RESENDE, MM
    BISSOLI, NS
    VASQUEZ, EC
    CABRAL, AM
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1995, 28 (06) : 621 - 625
  • [37] RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE IN BRIEF ISCHEMIA-REPERFUSION IN ISOLATED RAT HEARTS
    ARAD, M
    ZAMIR, N
    HOROWITZ, L
    OXMAN, T
    RABINOWITZ, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05): : H1971 - H1978
  • [38] Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy
    Kitaoka, H
    Hitomi, N
    Yabe, T
    Furuno, T
    Doi, YL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (11): : 1318 - 1320
  • [39] Immunohistochemical expression of atrial natriuretic peptide (ANP) in the conducting system and internodal atrial myocardium of human hearts
    Benvenuti, LA
    Aiello, VD
    Higuchi, MD
    Palomino, SAP
    [J]. ACTA HISTOCHEMICA, 1997, 99 (02) : 187 - 193
  • [40] HUMAN ATRIAL-NATRIURETIC-PEPTIDE
    ESPINER, EA
    NICHOLLS, MG
    [J]. CLINICAL ENDOCRINOLOGY, 1987, 26 (05) : 637 - 650